PI
JAZZ icon

PineBridge Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

PineBridge Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,862
Closed -$285K – 719
2020
Q1 		$285K Sell
2,862
-54,795
-95% -$7.08M 0.01% 463
2019
Q4 		$8.61M Sell
57,657
-5,070
-8% -$690K 0.13% 180
2019
Q3 		$8.04M Sell
62,727
-20,505
-25% -$2.75M 0.13% 185
2019
Q2 		$11.9M Sell
83,232
-15,156
-15% -$2.04M 0.19% 139
2019
Q1 		$14.1M Sell
98,388
-8,129
-8% -$1.06M 0.29% 99
2018
Q4 		$13.2M Buy
106,517
+59,416
+126% +$8.81M 0.29% 95
2018
Q3 		$7.92M Buy
+47,101
New +$8.1M 0.15% 169
2016
Q3 		– Sell
-25,565
Closed -$3.61M – 1149
2016
Q2 		$3.61M Buy
25,565
+394
+2% +$58.1K 0.19% 144
2016
Q1 		$3.29M Buy
25,171
+80
+0.3% +$9.96K 0.17% 139
2015
Q4 		$3.53M Sell
25,091
-1,050
-4% -$146K 0.15% 160
2015
Q3 		$3.47M Buy
26,141
+20,487
+362% +$3.53M 0.15% 147
2015
Q2 		$996K Buy
+5,654
New +$1.02M 0.04% 251

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

PineBridge Investments's JAZZ Position: Q2 2020 in Review

PineBridge Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 2,862 shares — an estimated $285K sold.

PineBridge Investments first reported a position in JAZZ in Q2 2015 and held it in 12 quarters. The position peaked at $14.1M in Q1 2019. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • PineBridge Investments reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • PineBridge Investments sold 2,862 Jazz Pharmaceuticals shares in Q2 2020, an estimated $285K.
  • PineBridge Investments first reported a position in Jazz Pharmaceuticals in Q2 2015 and held it in 12 quarters.
  • PineBridge Investments's Jazz Pharmaceuticals position peaked at $14.1M in Q1 2019.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on PineBridge Investments's 13F filing for Q2 2020, filed 13 Aug 2020.